AbbVie

No reviews yet · Write a Review
AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions.

Company Details

Address
1 North Waukegan Road
North Chicago, IL 60064

Competitors of AbbVie

GEA supplies advanced processing technologies for the manufacturing of oral and parenteral dosage forms. We partner with customers to develop new products and enhance clinical effectiveness; the supply of R&D-scale and stand-alone production equipment; and installation of complete integrated... Read More

3 Products 0 White Papers 0 Press Releases

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Read More

0 Products 0 White Papers 0 Press Releases

UPM Pharmaceuticals Inc., a trailblazing contract development and manufacturing organization (CDMO), emerges as a beacon of innovation and excellence in the pharmaceutical manufacturing industry. Anchored in our ethos of integrity and quality, we are an independent, family-owned enterprise that... Read More

0 Products 0 White Papers 0 Press Releases

News & Press Releases

View All
Press Release

JUVÉDERM® Day Returns to U.S. on August 19

Published: 7/30/2026
Press Release

SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease

Published: 6/26/2026
Press Release

AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026

Published: 6/8/2026
Press Release

AbbVie to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Published: 6/2/2026
Press Release

AbbVie to Present at the Bank of America Securities Healthcare Conference

Published: 5/6/2026
Press Release

Allergan Aesthetics Launches Philanthropic Effort in Recognition of Skin Cancer Awareness Month

Published: 4/30/2026
Press Release

AbbVie Provides Update on TrenibotulinumtoxinE (TrenibotE) Biologics License Application in the U.S.

Published: 4/23/2026
Press Release

AbbVie Selects North Carolina for New $1.4 Billion Manufacturing Campus

Published: 4/22/2026
Press Release

Erin Lichy Gets Real About Her Natrelle® Breast Augmentation

Published: 4/14/2026